6 High-Conviction Value Picks for 2026: Wide Moats at a Discount

The market's mood has shifted. For years, it felt like walking through a casino where almost every table paid out. From 2020 through 2024, simply "putting chips on the table" worked unusually well, with more than half of S&P 500 companies delivering annualized returns above 15%. That era is ending. As 2025 winds down, around 40% of the index is heading for a negative year. The lights are coming up, and the house edge is reasserting itself. This is the setup for 2026: a return to an investor's market, where patience and discipline are rewarded over chasing hot trades.

The numbers confirm a broader correction. As of late 2025, the overall US equity market was trading at a 4% discount to a composite of fair value estimates. This gap is the opportunity. It signals that while the market as a whole has pulled back, the intrinsic value of its underlying businesses has been revised upward, particularly for mega-caps. The result is a landscape where high-quality companies are no longer commanding premium prices for their future potential. For the long-term investor, this is a classic entry point.

History shows the power of this approach. The strategy of focusing on wide-moat companies trading at a discount to intrinsic value is not new; it is the bedrock of value investing. It has consistently outperformed over full market cycles because it prioritizes durable competitive advantages and a margin of safety. The Morningstar Wide Moat Focus Index, which tracks exactly these characteristics, is a living example. As of September, it highlighted stocks like Constellation Brands and TransUnion trading at significant discounts to their estimated worth. These are the fertile hunting grounds for investors willing to wait for the market to recognize true value.

The coming year will likely be volatile, with risks from economic shifts and political noise. But volatility is the investor's friend when it creates mispricings. The core thesis is straightforward: in a market that is no longer a casino, the highest-probability outcome is found by sizing positions thoughtfully in companies with wide moats, buying them at a discount, and letting time do the rest.

Merck & Co. (MRK): A Pharmaceutical Moat at a 27% Discount

Merck presents a classic value case: a wide-moat business trading at a significant discount. The company's economic moat is built on two pillars. First, its established brand and global distribution network provide a formidable barrier to entry in the pharmaceutical sector. Second, and more critically, its robust pipeline of oncology drugs offers a durable source of future growth. This combination of a proven track record and a forward-looking pipeline creates a business with the potential to compound value for decades.

The valuation tells a clear story of opportunity. As of mid-November 2025, a discounted cash flow model projecting five years of growth estimated Merck's intrinsic value at $118.03 per share. With the stock trading around $92.93, that implies a 27% discount to intrinsic value. This margin of safety is substantial, especially for a company of Merck's scale and resilience. It suggests the market is pricing in a more cautious outlook for its future cash flows than a disciplined analysis of its competitive position and pipeline would support.

Underpinning this potential is the steady cash flow generated by its blockbuster products. Drugs like Keytruda provide a reliable foundation, funding the company's operations, its research and development engine, and its shareholder returns. This financial strength is the bedrock of long-term compounding. It allows Merck to weather the inevitable cycles of drug development and regulatory review, reinvesting in its moat while returning capital to shareholders. For the patient investor, this setup-high-quality cash flows at a discount-aligns perfectly with the value investing principle of buying a dollar for fifty cents.

Visa (V): The Unassailable Payment Moat at a Modest Discount

Visa's business is built on an economic moat so wide it borders on the unassailable. Its power stems from a simple, self-reinforcing truth: the more people and merchants that use its network, the more valuable it becomes to everyone. This creates immense switching costs. With 4.9 billion Visa payment cards worldwide, the network effect is global and entrenched. For a merchant, accepting Visa means reaching that vast base of consumers. For a consumer, carrying a Visa card means universal acceptance. This scale is the foundation of its dominance.

The company's financial model is the perfect expression of a durable moat. Visa earns a small fee on each transaction, but the volume is staggering. In its 2025 fiscal year, it processed 257.5 billion transactions worth $14.2 trillion in payments volume. This creates a recurring revenue stream that is both massive and highly predictable. The fees are collected at the point of sale, long before the merchant's cash hits the bank. This flow of capital is the engine of its profitability, which topped $20.1 billion in net income last year. For a long-term compounder, this is the ideal cash flow profile: steady, high-margin, and protected by network effects.

This is why Visa is a core holding in the Morningstar Wide Moat Focus Index. The index specifically targets companies with wide economic moats that are trading at low prices relative to their estimated fair value. Visa's inclusion is a recognition of its structural advantages. While the stock may not trade at a deep discount like some other wide-moat names, its valuation reflects a premium for quality. The key for the value investor is to assess whether that premium is justified by the durability of the moat and the company's ability to convert its immense transaction volume into shareholder returns over the long term. In a world where payment networks are a utility, Visa's scale and acceptance create a fortress that is unlikely to be breached.

Chevron (CVX): Energy Income with Long-Term Staying Power

For the value investor, the ideal holding is a business with a durable moat that generates reliable cash flow, returns capital to shareholders, and can be held for the long term. Chevron fits this profile perfectly. The company's integrated global operations create a formidable competitive advantage. Its scale in exploration, production, refining, and marketing allows it to navigate the cyclical nature of the energy industry. This breadth, combined with a strong balance sheet, provides the financial flexibility to invest through downturns while maintaining its commitment to shareholders-a hallmark of a true compounder.

The company's capital allocation strategy is a direct alignment with value investing principles. Chevron has a long history of returning capital to investors through a growing dividend and share buybacks. As a dividend aristocrat with 38 consecutive years of dividend increases, it demonstrates disciplined stewardship. The current yield, coupled with a substantial annualized payout, provides a tangible income stream. For a patient investor, this is not just a dividend; it is a signal of management's confidence in the business's ability to produce excess cash over time.

More broadly, Chevron's business model offers a tangible hedge against inflation and a steady stream of cash flow, enhancing its resilience. Energy is a necessity, and the company's integrated model ensures it captures value across the entire supply chain. This structure provides a level of predictability that is rare in volatile markets. While the stock's total return over the last three years has been modest, reflecting the pressure of a subdued oil price environment, its 10-year total return of over 200% underscores its long-term staying power. In a world of fleeting trades, Chevron represents the opposite-a business built to compound value through decades of economic cycles.

Intel (INTC): A Potential Turnaround with Government Backing

Intel's current situation is a classic value setup: a company with a once-dominant moat facing severe execution challenges, but trading at a deep discount with a clear catalyst on the horizon. The stock's recent struggles have created a wide margin of safety, a key requirement for any value investor. Crucially, it is NOT at it's ATH or even close. This avoids the "catching falling knives" risk and provides a cushion if the turnaround takes longer than expected. For a patient investor, the goal is not to time the bottom, but to buy a business at a price that offers a significant buffer against further deterioration.

The primary catalyst for a re-rating lies in geopolitical and industrial policy. The Western governments' push for domestic chip production is a powerful tailwind. As one analyst noted, the western govs want chip sovereignty so there's potential for huge gov support. This isn't just theoretical; it includes direct funding, tax incentives, and procurement advantages. For Intel, which has been rebuilding its manufacturing capabilities, this government backing could provide the essential financial and strategic support to close the technological gap with competitors. It transforms a purely commercial challenge into one with a potential public-sector solution.

The opportunity, then, is a binary one. If Intel can successfully execute its turnaround plan-regaining process leadership, stabilizing its product roadmap, and regaining market share-it could see a significant re-rating. The government support acts as a powerful catalyst that could accelerate that process. The current valuation offers a potential margin of safety for that bet. The stock's depressed state already prices in a high probability of continued struggle. A successful execution, backed by policy, would force a reassessment of the company's intrinsic value.

The risk is execution. Intel's past missteps are well-documented, and the company must prove it can deliver on its promises. Yet for a value investor, the calculus changes when the downside is capped by a discount and the upside is potentially amplified by a powerful external force. Intel represents a bet on a company with a deep-pocketed ally and a clear path to re-establishing its competitive position. It is a higher-risk, higher-potential-reward play within the value framework, but one that meets the core criteria: a tangible business with a catalyst, trading at a price that does not demand perfection.

Caterpillar (CAT): The Industrial Moat in a Capital-Intensive Cycle

Caterpillar's business is a study in durable competitive advantage. Its moat is built on the same pillars that define wide-moat companies: brand strength, economies of scale, and high customer switching costs. In the heavy equipment industry, where reliability and service are paramount, Caterpillar's iconic yellow machines are synonymous with quality. This brand loyalty, combined with a global service and parts network, creates immense friction for customers considering a switch. The cost and operational risk of changing suppliers for critical, capital-intensive machinery are simply too high. This entrenched position protects its pricing power and profit margins, even during economic cycles.

The company's strategic positioning is now aligning with two powerful secular trends. First, it is a direct beneficiary of the global infrastructure build-out. In the United States, the Infrastructure Investment and Jobs Act is creating a multi-year tailwind for its construction equipment portfolio. More broadly, the shift toward clean energy will drive demand for essential commodities, boosting the need for its mining equipment. Second, and perhaps more uniquely, Caterpillar is capturing a new growth vector in the data center power market. As technology companies establish facilities worldwide to support artificial intelligence, the demand for reliable, efficient power generation is surging. Caterpillar is planning to double its output of reciprocating engines for data centers, a move backed by a long-term strategic collaboration with Hunt Energy Company. This isn't a fleeting trend; it's a direct play on the foundational infrastructure of the digital economy.

This dual exposure to physical infrastructure and digital power creates a compelling long-term growth story. The result is a business generating durable, high-margin cash flows. These flows are the fuel for its capital allocation, which has been consistently shareholder-friendly. The company has a long history of returning capital through dividends and buybacks, a hallmark of a business that understands the power of compounding. For the patient investor, this setup is ideal: a wide-moat industrial giant with a proven ability to convert its scale and brand into cash, now positioned at the intersection of two enduring secular trends. It represents a classic value compounder-buying a dollar for fifty cents and letting time and a widening moat do the rest.

Catalysts, Risks, and The Patient Investor's Guardrails

The path from current price to intrinsic value for these wide-moat names is not a sprint, but a journey that demands patience. The primary catalyst for each is the successful execution of its long-term strategy. For Merck, it is the steady progression of its oncology pipeline into commercial success. For Visa, it is the continued expansion of its global payment network and the monetization of new growth vectors like data center power. For Intel, it is the flawless execution of its manufacturing turnaround, amplified by government support. These are not quarterly events, but multi-year processes that will determine whether the market's current discount is justified.

A key risk that could prolong underperformance across all these picks is a broader market downturn or sector-specific headwinds. The market's current 4% discount to composite fair value suggests a cautious mood, but sentiment can shift quickly. A recession or a spike in interest rates could pressure valuations further, regardless of individual company strength. Similarly, sector-specific issues-such as regulatory changes for pharmaceuticals, shifts in global trade for industrial equipment, or a slowdown in tech spending impacting payment volumes-could delay the re-rating. The Morningstar Wide Moat Focus Index highlights that these are high-quality stock ideas, but quality does not guarantee immunity from external shocks.

For the value investor, the main guardrail is patience. The modest to moderate discounts seen in these picks-like Merck's 27% gap or the 3% upside for Adobe-do not promise immediate fireworks. They represent a margin of safety that is meaningful but not spectacular. The payoff requires a long-term horizon, allowing time for the business moats to widen and for the market to recognize the true value of durable cash flows. In a market that is no longer a casino, this discipline is the ultimate edge. It is the choice to wait for the right price on a dollar bill, knowing that the intrinsic value will eventually be realized.